INOVIO: Clinical Proof of Mechanism

OracleBio Case Study

Note: Permission has been granted for the use of this material

Study Background

This case study focuses on histopathological evaluation of immune cell types within cervical dysplasia samples from INOVIO clinical trials, with the aim to provide evidence of therapeutic mechanism of action.


INOVIO is a biotechnology company committed to powering a new way forward in DNA medicines to help save and protect lives worldwide. The company is focused on developing and commercializing DNA medicines to potentially treat and protect people from infectious diseases, cancer, and diseases associated with HPV.

View the Case Study

Click the thumbnail below to view the case study PDF:

Multiplex Digital Phenotyping of the Tumour Microenvironment AACR 2021

Benefits of Working with OracleBio for your Clinical Studies:


  • Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
  • Work alongside Clinical Project managers – experienced with ensuring data parity between time-separated batches of clinical samples